Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1Neurofibrosarcoma 1Colorectal Neoplasms 1

Interventions

selinexor 2Radiotherapy 2Magnetic Resonance Spectroscopy 2Doxorubicin 2ribociclib 1pembrolizumab 1pegfilgrastim 1metarrestin 1ixazomib 1fludarabine phosphate 1fludarabine 1cixutumumab 1X-Rays 1Specimen Handling 1Radiation 1Photons 1Nivolumab 1Mesna 1Ifosfamide 1High-Energy Shock Waves 1Filgrastim 1Cyclophosphamide 1Chemotherapy, Adjuvant 1Celecoxib 1Biopsy 1BO-112 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Neurofibrosarcoma × metarrestin × Clear all
NCT04222413 2026-04-24

Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting
116 enrolled
GastrointestinalSarcoma

Pancreatic Neoplasms, Colorectal Neoplasms, Neurofibrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡